Non-medical use of benzodiazepines and GABA analogues in Europe.
Joanna HockenhullElise AmiokaJoshua C BlackAlyssa ForberColleen M HaynesDavid M WoodRichard C DartDavid Michael WoodPublished in: British journal of clinical pharmacology (2020)
This study shows that there is variation in NMU of benzodiazepines and GABA analogues among countries. Of particular interest is the high incidence of GABA analogue NMU in Germany and benzodiazepine NMU in Spain. Further research to identify factors and motivations responsible for the higher prevalence observed are essential to inform public health policies in those countries.